Deutsche Bank
DAWN

Deutsche Bank’s Day One Biopharmaceuticals DAWN Stock Holding History

Deutsche Bank’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
66,445
+9,435
+17% +$133K ﹤0.01% 1975
2025
Q4 		$531K Buy
57,010
+15,506
+37% +$130K ﹤0.01% 2533
2025
Q3 		$293K Sell
41,504
-283,784
-87% -$1.95M ﹤0.01% 2865
2025
Q2 		$2.11M Sell
325,288
-9,234
-3% -$63.5K ﹤0.01% 1670
2025
Q1 		$2.65M Sell
334,522
-24,398
-7% -$263K ﹤0.01% 1569
2024
Q4 		$4.55M Buy
358,920
+35,460
+11% +$493K ﹤0.01% 1374
2024
Q3 		$4.51M Buy
323,460
+121,593
+60% +$1.73M ﹤0.01% 1316
2024
Q2 		$2.78M Buy
201,867
+23,693
+13% +$347K ﹤0.01% 1482
2024
Q1 		$2.94M Buy
178,174
+1,018
+0.6% +$15.2K ﹤0.01% 1481
2023
Q4 		$2.59M Buy
177,156
+19
+0% +$230 ﹤0.01% 1543
2023
Q3 		$2.17M Buy
177,137
+9,219
+5% +$120K ﹤0.01% 1322
2023
Q2 		$2M Sell
167,918
-417
-0.2% -$5.45K ﹤0.01% 1622
2023
Q1 		$2.25M Buy
168,335
+151,525
+901% +$2.96M ﹤0.01% 1625
2022
Q4 		$362K Buy
16,810
+5,212
+45% +$107K ﹤0.01% 2624
2022
Q3 		$232K Buy
11,598
+554
+5% +$11.8K ﹤0.01% 2861
2022
Q2 		$198K Sell
11,044
-2,219
-17% -$22.9K ﹤0.01% 3177
2022
Q1 		$132K Buy
13,263
+6,561
+98% +$86.7K ﹤0.01% 3471
2021
Q4 		$113K Buy
6,702
+363
+6% +$7.46K ﹤0.01% 3652
2021
Q3 		$150K Buy
+6,339
New +$152K ﹤0.01% 3704

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Deutsche Bank's DAWN Position: Q1 2026 in Review

Deutsche Bank increased its Day One Biopharmaceuticals (DAWN) stake by 17% in Q1 2026, buying an estimated $133K and bringing the position to 66,445 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Deutsche Bank first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.55M in Q4 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Deutsche Bank held 66,445 shares of Day One Biopharmaceuticals worth $1.42M as of Q1 2026.
  • Deutsche Bank bought 9,435 Day One Biopharmaceuticals shares in Q1 2026, an estimated $133K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1975 holding.
  • Deutsche Bank first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Deutsche Bank's Day One Biopharmaceuticals position peaked at $4.55M in Q4 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.